[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345865-105":59,"doc-detail-345865-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mettl3-driven-m6a-modification-promotes-tumor-progression-and-immune-evasion-in-hypoxic-pancreatic-cancer-research-article-summary","METTL3-driven m6A modification promotes tumor progression and immune evasion in hypoxic pancreatic cancer - Research Article Summary","","Pancreatic cancer progresses rapidly with poor survival and relies on immune evasion mechanisms, particularly under hypoxic tumor microenvironments. The study investigates how m6A methylation contributes to immune escape, focusing on METTL3 and its downstream signaling via ADAM10 and the shedding of MICA. Results from GEO analyses link increased METTL3 to HIF1A and elevated MICA, with hypoxia enhancing METTL3 activity. Functional experiments show METTL3 promotes survival and migration while suppressing NK cell activity, whereas METTL3 knockdown restores immune recognition and reduces tumor growth in vivo.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mettl3-driven-m6a-modification-promotes-tumor-progression-and-immune-evasion-in-hypoxic-pancreatic-cancer-research-article-summary/345865/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mettl3-driven-m6a-modification-promotes-tumor-progression-and-immune-evasion-in-hypoxic-pancreatic-cancer-research-article-summary/345865.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in pancreatic cancer?","Question",{"text":112,"@type":113},"Pancreatic cancer has rapid progression and poor survival, and cancer cells evade immune surveillance, especially under hypoxic conditions. The study targets the mechanism of immune evasion linked to m6A methylation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is METTL3 connected to hypoxia and immune escape?",{"text":117,"@type":113},"METTL3 levels increase in pancreatic cancer samples and are strongly associated with HIF1A, a key hypoxia-related factor. The high-HIF1A group shows higher METTL3 and MICA levels, and hypoxia further enhances METTL3 and m6A effects.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does METTL3 play in tumor cells and NK cell activity?",{"text":121,"@type":113},"In normoxic settings, METTL3 overexpression increases cell survival and migration while reducing apoptosis and immune evasion markers by lowering MICA-positive cells and increasing sMICA. It also decreases NKG2D-positive NK92 cells and impairs NK92-mediated cell death; hypoxic METTL3 knockdown has the opposite effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345865,1790386565,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":14,"preview_urls":145},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Zhang et al. Journal of Translational Medicine (2026) 24:935  \n[https://doi.org/10.1186/s12967-026-08238-3](https://doi.org/10.1186/s12967-026-08238-3)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nMETTL3-driven m6A modification promotes tumor progression and immune evasion in hypoxic pancreatic cancer by enhancing ADAM10-mediated MICA shedding  \nFan Zhang3,4,5†, Linwei Wang2†, Qizhen Chen1, Shuai Zhu1, Xuejun Gong1 andYebin Lu 1*  \nAbstract  \nBackground Pancreatic cancer is characterized by asymptomatic early stages, fast progression, and dismal survival rates. Therefore, a better understanding of immune evasion is required to create more effective treatments. m6Amethylation is linked to pancreatic cancer, particularly in hypoxia-induced immune escape.  \nResults GEO microarray datasets identified pancreatic cancer differentially expressed genes (DEGs) and m6A modification regulators. Compared with controls, pancreatic cancer samples showed increased METTL3 levels. METTL3 levels are strongly associated with HIF1A, a key component of the hypoxic tumor microenvironment, suggesting its involvement in tumor development and immune evasion. HIF1A expression levels divided pancreatic tumor tissues into high-and low-HIF1A groups. The high-HIF1A group showed higher METTL3 and MICA levels. Further histopathological, immunohistochemical, and m6A modification studies indicated that METTL3 expression and  \nm6A modification increased, especially under hypoxic conditions. In normoxic pancreatic cancer cell lines, METTL3 overexpression boosted cell survival, migration, reduced apoptosis, and facilitated immune evasion by lowering MICA-positive cells and increasing sMICA, decreasing NKG2D-positive NK92 cells, and impairing NK92 cell death. Hypoxic METTL3 knockdown reduced cell survival and migration, enhanced apoptosis, increased MICA-positive cells and decreased sMICA levels, and boosted NKG2D-positive NK92 cells and pancreatic cancer cell death, suggesting reduction of immune evasion. Moreover, the in vivo xenograft model further confirmed that METTL3 knockdown reduced tumor growth and increased NK cell infiltration. METTL3 stabilizes ADAM10 mRNA through m6A modification. Under hypoxic conditions, ADAM10 overexpression had effects opposite to those of METTL3 knockdown in pancreatic cancer cells and NK92 cells. It partially abolished METTL3’s effects, suggesting that m6A modification might mediate METTL3’s effects on hypoxia-related pancreatic cancer immune evasion.  \nConclusions In conclusion, targeting METTL3 or ADAM10, or intervention in the m6A modification pathway, may provide novel therapeutic avenues, particularly for pancreatic cancer cells’ immune-evasive tactics.  \n†Fan Zhang and Linwei Wang contributed equally to this work.  \n*Correspondence: Yebin Lu[luyebin6@csu.edu.cn](luyebin6@csu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommon","cbCaiajUqunDkDYb","https://ap.wps.com/l/cbCaiajUqunDkDYb","pdf",13677108,"English","# Abstract\n## Background\n## Results\n## Conclusions\n# Introduction\n## Immune evasion in pancreatic cancer\n## MICA/sMICA and NKG2D under hypoxia","[{\"question\":\"What problem does the study address in pancreatic cancer?\",\"answer\":\"Pancreatic cancer has rapid progression and poor survival, and cancer cells evade immune surveillance, especially under hypoxic conditions. The study targets the mechanism of immune evasion linked to m6A methylation.\"},{\"question\":\"How is METTL3 connected to hypoxia and immune escape?\",\"answer\":\"METTL3 levels increase in pancreatic cancer samples and are strongly associated with HIF1A, a key hypoxia-related factor. The high-HIF1A group shows higher METTL3 and MICA levels, and hypoxia further enhances METTL3 and m6A effects.\"},{\"question\":\"What role does METTL3 play in tumor cells and NK cell activity?\",\"answer\":\"In normoxic settings, METTL3 overexpression increases cell survival and migration while reducing apoptosis and immune evasion markers by lowering MICA-positive cells and increasing sMICA. It also decreases NKG2D-positive NK92 cells and impairs NK92-mediated cell death; hypoxic METTL3 knockdown has the opposite effects.\"}]","METTL3-driven m6A modification promotes tumor progression and immune evasion in hypoxic pancreatic cancer - Research Article Summary | PDF",1790059182,48,[146,150],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/caf5dc52e5f4b199bb068c2f2f8e1297.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/3756fc70911e6ec5c002af7d49e482b6.webp",982,1309]